24.2%
Anorexia / decreased appetite
Control: 1.0%
DOGS ANONYMOUSGLOBAL
Report an Experience →
FDA-reviewed canine studies already document adverse reactions during behavioral-medication use. These are study-specific frequencies — not universal rates for every dog or every medication.
| Medication | Reported behavioral finding | Study finding |
|---|---|---|
| Gabapentin | Sedation | 46% |
| Gabapentin | Agitation / irritability / restlessness / difficulty relaxing / vocalizing | 24% |
| Gabapentin | Ataxia | 18% |
| Fluoxetine | Increased aggression reported as an adverse experience in one canine clinical trial | 12% |
| Fluoxetine | Lethargy / depression category in FDA safety study | 18.2% |
| Fluoxetine | Diarrhea | 14.1% |
| Clomipramine | Vomiting | 20% |
| Clomipramine | Lethargy | 14% |
In a study of 50 dogs receiving gabapentin for behavioral disorders, 24% were reported to experience agitation — including irritability, restlessness, difficulty relaxing, and vocalizing. Every dog in the study with newly reported aggression was also reported to have agitation.
Different observers may see different parts of the same change. Real-world documentation helps turn isolated experiences into usable data.
See changes in daily behavior, sleep, appetite, play, interaction, and function at home.
May notice changes in motivation, learning, responsiveness, arousal, tolerance, and behavior under distraction.
Can document medication history, dose changes, physical effects, laboratory findings, and treatment response.
May observe behavioral or functional changes outside the home or across multiple environments and caregivers.
Clinical studies are designed to answer specific questions under defined conditions. Real life is messier — dogs may be on medication longer, receive multiple drugs, undergo dose changes, train at the same time, or experience effects that unfold gradually.
The registry preserves direct observations in a consistent format so medication history, timing, outcomes, and recurring patterns can be compared more meaningfully.
If you directly observed a negative, unexpected, or concerning change during behavioral-medication use, document the dog, the timeline, and what happened next.